{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:27Z","timestamp":1792783407906,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Kunming Health Science and Technology Talent Project","award":["2024-SW (take the lead)-21"],"award-info":[{"award-number":["2024-SW (take the lead)-21"]}]},{"name":"Health Research Project of Kunming Health Committee","award":["2023-02-05-005"],"award-info":[{"award-number":["2023-02-05-005"]}],"id":[{"id":"https:\/\/ror.org\/059qgvg50","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Scientific Research Project of Yunnan Education Department","award":["2024J0300"],"award-info":[{"award-number":["2024J0300"]}]},{"name":"Kunming Science and Technology Plan","award":["2023-1-NS-015"],"award-info":[{"award-number":["2023-1-NS-015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04373-x","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:53:42Z","timestamp":1777474422000},"page":"4915-4926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-138-5p inhibits WiT-49 cell growth in vitro by downregulating TCF3 expression, and suppresses tumorigenesis in vivo"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4145-6882","authenticated-orcid":false,"given":"Zhigang","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangchenghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuilian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipeng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9650-747X","authenticated-orcid":false,"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"1","key":"4373_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00308-8","volume":"7","author":"F Spreafico","year":"2021","unstructured":"Spreafico F, Fernandez CV, Brok J, Nakata K, Vujanic G, Geller JI, et al. Wilms tumour. Nat Rev Dis Prim. 2021;7(1):75.","journal-title":"Nat Rev Dis Prim"},{"issue":"3","key":"4373_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ucl.2023.04.008","volume":"50","author":"AF Saltzman","year":"2023","unstructured":"Saltzman AF, Cost NG, Romao RLP. Wilms tumor. Urol Clin North Am. 2023;50(3):455\u201364.","journal-title":"Urol Clin North Am"},{"key":"4373_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejca.2016.09.005","volume":"68","author":"J Brok","year":"2016","unstructured":"Brok J, Treger TD, Gooskens SL, van den Heuvel-Eibrink MM, Pritchard-Jones K. Biology and treatment of renal tumours in childhood. Eur J Cancer. 2016;68:179\u201395.","journal-title":"Eur J Cancer"},{"issue":"8","key":"4373_CR4","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S1470-2045(18)30293-6","volume":"19","author":"J Brok","year":"2018","unstructured":"Brok J, Lopez-Yurda M, Tinteren HV, Treger TD, Furtw\u00e4ngler R, Graf N, et al. Relapse of Wilms tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms\u2019 tumour protocol database. Lancet Oncol. 2018;19(8):1072\u201381.","journal-title":"Lancet Oncol"},{"issue":"4","key":"4373_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41581-019-0112-0","volume":"15","author":"TD Treger","year":"2019","unstructured":"Treger TD, Chowdhury T, Pritchard-Jones K, Behjati S. The genetic changes of Wilms tumour. Nat Rev Nephrol. 2019;15(4):240\u201351.","journal-title":"Nat Rev Nephrol"},{"key":"4373_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1137346","volume":"13","author":"H Zheng","year":"2023","unstructured":"Zheng H, Liu J, Pan X, Cui X. Biomarkers for patients with Wilms tumor: a review. Front Oncol. 2023;13:1137346.","journal-title":"Front Oncol"},{"issue":"5","key":"4373_CR7","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.juro.2016.05.100","volume":"196","author":"EB Cone","year":"2016","unstructured":"Cone EB, Dalton SS, Van Noord M, Tracy ET, Rice HE, Routh JC. Biomarkers for Wilms tumor: a systematic review. J Urol. 2016;196(5):1530\u20135.","journal-title":"J Urol"},{"issue":"4","key":"4373_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.36401\/JIPO-20-12","volume":"3","author":"KZ Hein","year":"2020","unstructured":"Hein KZ, Yao S, Fu S. Wilms tumor 1 (WT1): the vaccine for cancer. J Immunother Precis Oncol. 2020;3(4):165\u201371.","journal-title":"J Immunother Precis Oncol"},{"issue":"1","key":"4373_CR9","doi-asserted-by":"publisher","first-page":"F3","DOI":"10.1152\/ajprenal.00248.2023","volume":"326","author":"E Torban","year":"2024","unstructured":"Torban E, Goodyer P. Wilms tumor gene 1: lessons from the interface between kidney development and cancer. Am J Physiol Renal Physiol. 2024;326(1):F3\u2013f19.","journal-title":"Am J Physiol Renal Physiol"},{"key":"4373_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.00337","volume":"8","author":"FJ P\u00e9rez-Linares","year":"2020","unstructured":"P\u00e9rez-Linares FJ, P\u00e9rezpe\u00f1a-Diazconti M, Garc\u00eda-Quintana J, Baay-Guzm\u00e1n G, Cabrera-Mu\u00f1oz L, Sadowinski-Pine S, et al. MicroRNA profiling in Wilms tumor: identification of potential biomarkers. Front Pediatr. 2020;8:337.","journal-title":"Front Pediatr"},{"key":"4373_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154523","volume":"246","author":"M Taheri","year":"2023","unstructured":"Taheri M, Hussen BM, Abdullah SR, Ghafouri-Fard S, Jamali E, Shojaei S. Dysregulation of non-coding RNAs in Wilms tumor. Pathol Res Pract. 2023;246:154523.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"4373_CR12","first-page":"236","volume":"14","author":"K Felekkis","year":"2010","unstructured":"Felekkis K, Touvana E, Stefanou C, Deltas C. MicroRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia. 2010;14(4):236\u201340.","journal-title":"Hippokratia"},{"key":"4373_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng Y, Croce CM. The role of microRNAs in human cancer. Signal Transduct Target Ther. 2016;1:15004.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"4373_CR14","first-page":"140","volume":"29","author":"L Zhang","year":"2023","unstructured":"Zhang L, Shao W. MicroRNA-143-3p inhibits Wilms tumor cell growth by targeting the Ras\/Raf\/MEK\/ERK pathway. Altern Ther Health Med. 2023;29(2):140\u20137.","journal-title":"Altern Ther Health Med"},{"issue":"8","key":"4373_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00397-21","volume":"42","author":"ZT Guo","year":"2022","unstructured":"Guo ZT, Yu Q, Miao C, Ge W, Li P. MicroRNA-27a-5p inhibits proliferation, migration, and invasion and promotes apoptosis of Wilms tumor cell by targeting PBOV1. Mol Cell Biol. 2022;42(8):e0039721.","journal-title":"Mol Cell Biol"},{"issue":"29","key":"4373_CR16","doi-asserted-by":"publisher","first-page":"45370","DOI":"10.18632\/oncotarget.9659","volume":"7","author":"L Zhao","year":"2016","unstructured":"Zhao L, Yu H, Yi S, Peng X, Su P, Xiao Z, et al. The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer. Oncotarget. 2016;7(29):45370\u201384.","journal-title":"Oncotarget"},{"issue":"12","key":"4373_CR17","first-page":"11516","volume":"10","author":"X Wang","year":"2017","unstructured":"Wang X, Zhao Y, Cao W, Wang C, Sun B, Chen J, et al. miR-138-5p acts as a tumor suppressor by targeting hTERT in human colorectal cancer. Int J Clin Exp Pathol. 2017;10(12):11516\u201325.","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"4373_CR18","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/1759-7714.14791","volume":"14","author":"J Wu","year":"2023","unstructured":"Wu J, Han X, Yang X, Li Y, Liang Y, Sun G, et al. MiR-138-5p suppresses the progression of lung cancer by targeting SNIP1. Thorac Cancer. 2023;14(6):612\u201323.","journal-title":"Thorac Cancer"},{"key":"4373_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7318950","volume":"2022","author":"H Liu","year":"2022","unstructured":"Liu H, Tang T, Hu X, Tan W, Zhou P, Zhang H, et al. miR-138-5p inhibits vascular mimicry by targeting the HIF-1\u03b1\/VEGFA pathway in hepatocellular carcinoma. J Immunol Res. 2022;2022:7318950.","journal-title":"J Immunol Res"},{"issue":"4","key":"4373_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1193","volume":"8","author":"H Huang","year":"2020","unstructured":"Huang H, Xiong Y, Wu Z, He Y, Gao X, Zhou Z, et al. MIR-138-5P inhibits the progression of prostate cancer by targeting FOXC1. Mol Genet Genomic Med. 2020;8(4):e1193.","journal-title":"Mol Genet Genomic Med"},{"issue":"7","key":"4373_CR21","doi-asserted-by":"publisher","first-page":"11071","DOI":"10.18632\/oncotarget.14360","volume":"8","author":"S Tian","year":"2017","unstructured":"Tian S, Guo X, Yu C, Sun C, Jiang J. miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1. Oncotarget. 2017;8(7):11071\u201382.","journal-title":"Oncotarget"},{"issue":"8","key":"4373_CR22","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.biocel.2007.05.014","volume":"40","author":"C Slattery","year":"2008","unstructured":"Slattery C, Ryan MP, McMorrow T. E2A proteins: regulators of cell phenotype in normal physiology and disease. Int J Biochem Cell Biol. 2008;40(8):1431\u20136.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"4373_CR23","doi-asserted-by":"publisher","first-page":"12516","DOI":"10.1080\/21655979.2022.2076481","volume":"13","author":"X Yu","year":"2022","unstructured":"Yu X, Li Z, Bai R, Tang F. Transcriptional factor 3 binds to sirtuin 1 to activate the Wnt\/\u03b2-catenin signaling in cervical cancer. Bioengineered. 2022;13(5):12516\u201331.","journal-title":"Bioengineered"},{"key":"4373_CR24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1600-065X.2000.imr017514.x","volume":"175","author":"BL Kee","year":"2000","unstructured":"Kee BL, Quong MW, Murre C. E2A proteins: essential regulators at multiple stages of B-cell development. Immunol Rev. 2000;175:138\u201349.","journal-title":"Immunol Rev"},{"key":"4373_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104301","volume":"104","author":"H Jia","year":"2020","unstructured":"Jia H, Wu D, Zhang Z, Li S. TCF3-activated FAM201A enhances cell proliferation and invasion via miR-186-5p\/TNKS1BP1 axis in triple-negative breast cancer. Bioorg Chem. 2020;104:104301.","journal-title":"Bioorg Chem"},{"issue":"4","key":"4373_CR26","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/coa.12834","volume":"42","author":"X Shen","year":"2017","unstructured":"Shen X, Yuan J, Zhang M, Li W, Ni B, Wu Y, et al. The increased expression of TCF3 is correlated with poor prognosis in Chinese patients with nasopharyngeal carcinoma. Clin Otolaryngol. 2017;42(4):824\u201330.","journal-title":"Clin Otolaryngol"},{"issue":"7","key":"4373_CR27","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1097\/IGC.0000000000001032","volume":"27","author":"L Luo","year":"2017","unstructured":"Luo L, Zhang H, Nian S, Lv C, Ni B, Wang D, et al. Up-regulation of transcription factor 3 is correlated with poor prognosis in cervical carcinoma. Int J Gynecol Cancer. 2017;27(7):1422\u201330.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"4373_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bbrc.2012.04.126","volume":"422","author":"D Patel","year":"2012","unstructured":"Patel D, Chaudhary J. Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis. Biochem Biophys Res Commun. 2012;422(1):146\u201351.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"4373_CR29","doi-asserted-by":"publisher","first-page":"10228","DOI":"10.1002\/jcb.28307","volume":"120","author":"Z Liu","year":"2019","unstructured":"Liu Z, Wu M, Shi H, Huang C, Luo S, Song X. DDN-AS1-miR-15a\/16-TCF3 feedback loop regulates tumor progression in cervical cancer. J Cell Biochem. 2019;120(6):10228\u201338.","journal-title":"J Cell Biochem"},{"issue":"6","key":"4373_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27727","volume":"10","author":"Y Sun","year":"2024","unstructured":"Sun Y, Sun J, Ying K, Chen J, Chen T, Tao L, et al. EP300 regulates the SLC16A1-AS1-AS1\/TCF3 axis to promote lung cancer malignancies through the Wnt signaling pathway. Heliyon. 2024;10(6):e27727.","journal-title":"Heliyon"},{"issue":"45","key":"4373_CR31","doi-asserted-by":"publisher","first-page":"12739","DOI":"10.1073\/pnas.1605938113","volume":"113","author":"K Taniue","year":"2016","unstructured":"Taniue K, Kurimoto A, Takeda Y, Nagashima T, Okada-Hatakeyama M, Katou Y, et al. ASBEL\u2013TCF3 complex is required for the tumorigenicity of colorectal cancer cells. Proc Natl Acad Sci U S A. 2016;113(45):12739\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4373_CR32","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12281","author":"N Zhou","year":"2021","unstructured":"Zhou N, Yan B, Ma J, Jiang H, Li L, Tang H, et al. Expression of TCF3 in Wilms tumor and its regulatory role in kidney tumor cell viability, migration and apoptosis in\u00a0vitro. Mol Med Rep. 2021. https:\/\/doi.org\/10.3892\/mmr.2021.12281.","journal-title":"Mol Med Rep"},{"issue":"6","key":"4373_CR33","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/ijc.31834","volume":"144","author":"T Kehl","year":"2019","unstructured":"Kehl T, Schneider L, Kattler K, St\u00f6ckel D, Wegert J, Gerstner N, et al. The role of TCF3 as potential master regulator in blastemal Wilms tumors. Int J Cancer. 2019;144(6):1432\u201343.","journal-title":"Int J Cancer"},{"issue":"20","key":"4373_CR34","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1182\/blood-2011-06-361972","volume":"118","author":"E Leich","year":"2011","unstructured":"Leich E, Zamo A, Horn H, Haralambieva E, Puppe B, Gascoyne RD, et al. MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. Blood. 2011;118(20):5550\u20138.","journal-title":"Blood"},{"issue":"3","key":"4373_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ygyno.2017.01.018","volume":"145","author":"H Li","year":"2017","unstructured":"Li H, Sheng Y, Zhang Y, Gao N, Deng X, Sheng X. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene. Gynecol Oncol. 2017;145(3):569\u201376.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"4373_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, Calif). 2001;25(4):402\u20138.","journal-title":"Methods (San Diego, Calif)"},{"key":"4373_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109880","volume":"125","author":"X Luo","year":"2020","unstructured":"Luo X, Dong J, He X, Shen L, Long C, Liu F, et al. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway. Biomed Pharmacother. 2020;125:109880.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"4373_CR38","first-page":"6623","volume":"24","author":"GZ Zhao","year":"2020","unstructured":"Zhao GZ, Niu YQ, Li ZM, Kou D, Zhang L. MiR-200c inhibits proliferation and promotes apoptosis of Wilms tumor cells by regulating akt signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(12):6623\u201331.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"4373_CR39","first-page":"5996","volume":"24","author":"B Luo","year":"2020","unstructured":"Luo B, Ma L, Xing X, Wang ZR, Teng Q, Li SG. MiR-22-3p regulates the proliferation and invasion of Wilms tumor cells by targeting AKT3. Eur Rev Med Pharmacol Sci. 2020;24(11):5996\u20136004.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4373_CR40","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2147\/OTT.S148684","volume":"11","author":"X Jiang","year":"2018","unstructured":"Jiang X, Li H. MiR-1180-5p regulates apoptosis of Wilms tumor by targeting p73. OncoTargets Ther. 2018;11:823\u201331.","journal-title":"OncoTargets Ther"},{"issue":"1","key":"4373_CR41","first-page":"12","volume":"52","author":"ZH Chen","year":"2022","unstructured":"Chen ZH, Cui MY, Zhang HM. EMX2OS delays Wilms tumor progression via targeting miR-654-3p. Ann Clin Lab Sci. 2022;52(1):12\u201320.","journal-title":"Ann Clin Lab Sci"},{"issue":"5","key":"4373_CR42","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/carcin\/bgs113","volume":"33","author":"W Wang","year":"2012","unstructured":"Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis. 2012;33(5):1113\u201320.","journal-title":"Carcinogenesis"},{"issue":"1","key":"4373_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000343349","volume":"31","author":"H Zhang","year":"2013","unstructured":"Zhang H, Zhang H, Zhao M, Lv Z, Zhang X, Qin X, et al. MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer. Cell Physiol Biochem. 2013;31(1):56\u201365.","journal-title":"Cell Physiol Biochem"},{"issue":"13","key":"4373_CR44","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.4161\/cc.20898","volume":"11","author":"X Liu","year":"2012","unstructured":"Liu X, Lv XB, Wang XP, Sang Y, Xu S, Hu K, et al. MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. Cell Cycle. 2012;11(13):2495\u2013506.","journal-title":"Cell Cycle"},{"issue":"3","key":"4373_CR45","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s12640-022-00510-w","volume":"40","author":"W Zeng","year":"2022","unstructured":"Zeng W, Jiang H, Wang Y, Wang C, Yu B. TCF3 induces DNMT1 expression to regulate Wnt signaling pathway in Glioma. Neurotox Res. 2022;40(3):721\u201332.","journal-title":"Neurotox Res"},{"issue":"10","key":"4373_CR46","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1080\/10428194.2022.2076852","volume":"63","author":"J Man","year":"2022","unstructured":"Man J, Wang H, Qian X, Chen L, Ma Y, Qian M, et al. TCF3 protein was highly expressed in pediatric Burkitt lymphoma and predicts poor prognosis: a single-center study. Leuk Lymphoma. 2022;63(10):2453\u201360.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"4373_CR47","doi-asserted-by":"publisher","first-page":"7995","DOI":"10.1080\/21655979.2021.1977557","volume":"12","author":"L Dong","year":"2021","unstructured":"Dong L, Huang J, Zu P, Liu J, Gao X, Du J, et al. Transcription factor 3 (TCF3) combined with histone deacetylase 3 (HDAC3) down-regulates microRNA-101 to promote Burkitt lymphoma cell proliferation and inhibit apoptosis. Bioengineered. 2021;12(1):7995\u20138005.","journal-title":"Bioengineered"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04373-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:03:01Z","timestamp":1790164981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04373-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["4373"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04373-x","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Kunming Children\u2019s Hospital (2023\u201103\u2011221\u2011K01).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all of the participants recruited into this study, which was carried out in accordance with the World Medical Association Declaration of Helsinki. All animal experiments were approved by the Animal Ethics Committee of Kunming Medical University (kmmu20241218), and were strictly implemented in compliance with the NIH Guide for the Care and Use of Laboratory Animals. All methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}